- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 601560, 10 pages
Adult Bone Marrow: Which Stem Cells for Cellular Therapy Protocols in Neurodegenerative Disorders?
1GIGA-Neurosciences, University of Liège, 4000 Liège, Belgium
2GIGA-Development, Stem cells and Regeneative Medicine, University of Liège, 4000 Liège, Belgium
3Neurology Department, CHU, 4000 Liège, Belgium
Received 11 July 2011; Accepted 21 October 2011
Academic Editor: Ken-ichi Isobe
Copyright © 2012 Sabine Wislet-Gendebien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- K. Takahashi, K. Okita, M. Nakagawa, and S. Yamanaka, “Induction of pluripotent stem cells from fibroblast cultures,” Nature protocols, vol. 2, no. 12, pp. 3081–3089, 2007.
- I. H. Park, R. Zhao, J. A. West et al., “Reprogramming of human somatic cells to pluripotency with defined factors,” Nature, vol. 451, no. 7175, pp. 141–146, 2008.
- S. U. Kim and J. de Vellis, “Stem cell-based cell therapy in neurological diseases: a review,” Journal of Neuroscience Research, vol. 87, no. 10, pp. 2183–2200, 2009.
- R. Patani, A. J. Hollins, T. M. Wishart et al., “Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state,” Nature Communications, vol. 2, no. 1, article 214, 2011.
- A. Swistowski, J. Peng, Q. Liu et al., “Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions,” Stem Cells, vol. 28, no. 10, pp. 1893–1904, 2010.
- S. Wislet-Gendebien, G. Hans, P. Leprince, J. M. Rigo, G. Moonen, and B. Rogister, “Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype,” Stem Cells, vol. 23, no. 3, pp. 392–402, 2005.
- S. Wislet-Gendebien, F. Wautier, P. Leprince, and B. Rogister, “Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin,” Brain Research Bulletin, vol. 68, no. 1-2, pp. 95–102, 2005.
- G. L. Ming and H. Song, “Adult neurogenesis in the mammalian brain: significant answers and significant questions,” Neuron, vol. 70, no. 4, pp. 687–702, 2011.
- S. Gögel, M. Gubernator, and S. L. Minger, “Progress and prospects: stem cells and neurological diseases,” Gene Therapy, vol. 18, no. 1, pp. 1–6, 2010.
- J. H. Kordower, Y. Chu, R. A. Hauser, T. B. Freeman, and C. W. Olanow, “Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease,” Nature Medicine, vol. 14, no. 5, pp. 504–506, 2008.
- J. Y. Li, E. Englund, J. L. Holton et al., “Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation,” Nature Medicine, vol. 14, no. 5, pp. 501–503, 2008.
- I. Mendez, A. Vinuela, A. Astradsson et al., “Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years,” Nature Medicine, vol. 14, no. 5, pp. 507–509, 2008.
- D. R. Wakeman, H. B. Dodiya, and J. H. Kordower, “Cell transplantation and gene therapy in Parkinson's disease,” Mount Sinai Journal of Medicine, vol. 78, no. 1, pp. 126–158, 2011.
- S. C. Schwarz and J. Schwarz, “Translation of stem cell therapy for neurological diseases,” Translational Research, vol. 156, no. 3, pp. 155–160, 2010.
- D. Solter, “From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research,” Nature Reviews Genetics, vol. 7, no. 4, pp. 319–327, 2006.
- P. Bianco, M. Riminucci, S. Gronthos, and P. G. Robey, “Bone marrow stromal stem cells: nature, biology, and potential applications,” Stem Cells, vol. 19, no. 3, pp. 180–192, 2001.
- A. Hilfiker, C. Kasper, R. Hass, and A. Haverich, “Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation?” Langenbeck's Archives of Surgery, vol. 396, no. 4, pp. 489–497, 2011.
- S. Wislet-Gendebien, P. Leprince, G. Moonen, and B. Rogister, “Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells,” Journal of Cell Science, vol. 116, no. 16, pp. 3295–3302, 2003.
- S. Wislet-Gendebien, F. Wautier, E. Laudet, and B. Rogister, Does Neural Phenotypic Plasticity from Non-Neural Cells Really Exist?Cell Differentiation Research Developments, Nova Publisher, New York, NY, USA, 2008.
- N. Nagoshi, S. Shibata, Y. Kubota et al., “Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad,” Cell Stem Cell, vol. 2, no. 4, pp. 392–403, 2008.
- C. Kalcheim, “Mechanisms of early neural crest development: from cell specification to migration,” International Review of Cytology, vol. 200, pp. 143–196, 2000.
- J. G. Toma, I. A. McKenzie, D. Bagli, and F. D. Miller, “Isolation and characterization of multipotent skin-derived precursors from human skin,” Stem Cells, vol. 23, no. 6, pp. 727–737, 2005.
- G. M. Kruger, J. T. Mosher, S. Bixby, N. Joseph, T. Iwashita, and S. J. Morrison, “Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness,” Neuron, vol. 35, no. 4, pp. 657–669, 2002.
- H. Y. Li, E. H. Say, and X. F. Zhou, “Isolation and characterization of neural crest progenitors from adult dorsal root ganglia,” Stem Cells, vol. 25, no. 8, pp. 2053–2065, 2007.
- M. Sieber-Blum, M. Grim, Y. F. Hu, and V. Szeder, “Pluripotent neural crest stem cells in the adult hair follicle,” Developmental Dynamics, vol. 231, no. 2, pp. 258–269, 2004.
- C. E. Wong, C. Paratore, M. T. Dours-Zimmermann et al., “Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin,” Journal of Cell Biology, vol. 175, no. 6, pp. 1005–1015, 2006.
- S. Yoshida, S. Shimmura, N. Nagoshi et al., “Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea,” Stem Cells, vol. 24, no. 12, pp. 2714–2722, 2006.
- R. Pardal, P. Ortega-Sáenz, R. Durán, and J. Lopez-Barneo, “Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body,” Cell, vol. 131, no. 2, pp. 364–377, 2007.
- X. Jiang, D. H. Rowitch, P. Soriano, A. P. McMahon, and H. M. Sucov, “Fate of the mammalian cardiac neural crest,” Development, vol. 127, no. 8, pp. 1607–1616, 2000.
- A. Glejzer, E. Laudet, P. Leprince et al., “Wnt1 and BMP2: two factors recruiting multipotent neural crest progenitors isolated from adult bone marrow,” Cellular and Molecular Life Sciences, vol. 68, no. 12, pp. 2101–2114, 2011.
- L. Sommer, “Growth factors regulating neural crest cell fate decisions,” Advances in Experimental Medicine and Biology, vol. 589, pp. 197–205, 2006.
- G. U. Enzmann, R. L. Benton, J. F. Talbott, Q. Cao, and S. R. Whittemore, “Functional considerations of stem cell transplantation therapy for spinal cord repair,” Journal of Neurotrauma, vol. 23, no. 3-4, pp. 479–485, 2006.
- M. Sieber-Blum, “Epidermal neural crest stem cells and their use in mouse models of spinal cord injury,” Brain Research Bulletin, vol. 83, no. 5, pp. 189–193, 2010.
- S. L. Hu, H. S. Luo, J. T. Li et al., “Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells,” Critical Care Medicine, vol. 38, no. 11, pp. 2181–2189, 2010.
- A. Uccelli, F. Benvenuto, A. Laroni, and D. Giunti, “Neuroprotective features of mesenchymal stem cells,” Best Practice and Research: Clinical Haematology, vol. 24, no. 1, pp. 59–64, 2011.
- X. Zeng, Y. S. Zeng, Y. H. Ma et al., “Bone marrow mesenchymal stem cells in a three dimensional gelatin sponge scaffold Attenuate inflammation, promote angiogenesis and reduce cavity formation in experimental spinal cord injury,” Cell Transplantation. In press.
- X. Xu, N. Geremia, F. Bao, A. Pniak, M. Rossoni, and A. Brown, “Schwann cell co-culture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice,” Cell transplantation, vol. 20, no. 7, pp. 1065–1086, 2011.
- C. O. Miranda, C. A. Teixeira, M. A. Liz et al., “Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model of Krabbe's disease,” Stem Cells, vol. 29, no. 11, pp. 1738–1751, 2011.
- N. Scolding, “Adult stem cells and multiple sclerosis,” Cell Proliferation, vol. 44, supplement 1, pp. 35–38, 2011.
- N. Grigoriadis, A. Lourbopoulos, R. Lagoudaki et al., “Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis,” Experimental Neurology, vol. 230, no. 1, pp. 78–89, 2011.
- M. Meyer, P. Jensen, and J. Z. Rasmussen, “Stem cell therapy for neurodegenerative disorders,” Ugeskr Laeger, vol. 172, pp. 2604–2607, 2010.
- Y. S. Levy, M. Bahat-Stroomza, R. Barzilay et al., “Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease,” Cytotherapy, vol. 10, no. 4, pp. 340–352, 2008.
- Z. Zhang, X. Wang, and S. Wang, “Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson's disease,” In Vitro Cellular and Developmental Biology—Animal, vol. 44, no. 5-6, pp. 169–177, 2008.
- E. Vassos, M. Panas, A. Kladi, and D. Vassilopoulos, “Effect of CAG repeat length on psychiatric disorders in Huntington's disease,” Journal of Psychiatric Research, vol. 42, no. 7, pp. 544–549, 2008.
- M. DiFiglia, E. Sapp, K. O. Chase et al., “Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain,” Science, vol. 277, no. 5334, pp. 1990–1993, 1997.
- B. R. Snyder, A. M. Chiu, D. J. Prockop, and A. W. Chan, “Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease,” PLoS ONE, vol. 5, no. 2, Article ID e9347, 2010.
- D. J. Selkoe, “Alzheimer's disease: genes, pathogenesis and risk prediction,” Physiological Reviews, vol. 81, no. 2, p. 741, 2001.
- M. P. Mattson, “Pathways towards and away from Alzheimer's disease,” Nature, vol. 430, no. 7000, pp. 631–639, 2004.
- A. R. Simard, D. Soulet, G. Gowing, J. P. Julien, and S. Rivest, “Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease,” Neuron, vol. 49, no. 4, pp. 489–502, 2006.
- J. K. Lee, H. K. Jin, S. Endo, E. H. Schuchman, J. E. Carter, and J.-S. Bae, “Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-β deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses,” Stem Cells, vol. 28, no. 2, pp. 329–343, 2010.
- N. Nagoshi, S. Shibata, M. Nakamura, Y. Matsuzaki, Y. Toyama, and H. Okano, “Neural crest-derived stem cells display a wide variety of characteristics,” Journal of Cellular Biochemistry, vol. 107, no. 6, pp. 1046–1052, 2009.
- L. Sensebe, P. Bourin, and K. Tarte, “Good manufacturing practices production of mesenchymal stem/stromal cells,” Human Gene Therapy, vol. 22, no. 1, pp. 19–26, 2011.